Supplements labeled as hyaluronic acid tablets are being recalled because they contain two undeclared drugs, which could be fatally dangerous to those taking them.
MXBBB is voluntarily recalling one lot of UMARY Hyaluronic Acid tablets, which were sold to consumers throughout the U.S. as dietary supplements via Amazon.
After laboratory analysis by the U.S. Food and Drug Administration (FDA) confirmed that the tablets contained diclofenac and omeprazole, MXBBB announced the recall on Tuesday and the FDA followed suit on Wednesday.
Diclofenac is a non-steroidal anti-inflammatory drug (NSAID): a group of drugs which are prescribed to treat fever, pain and inflammation.
Taking NSAIDs without realizing it could increase the risk of cardiovascular events such as heart attacks and strokes, and the risk of damage to the gut, such as bleeding, ulcers and perforation of the stomach and intestines, which can be fatal.
Taking diclofenac could interact with other medications and is especially dangerous when an individual is taking other NSAIDs at the same time.
The other drug in UMARY supplement, omeprazole, is a proton pump inhibitor (PPI): a type of medicine used to treat stomach acid-related disorders, such as acid reflux and heartburn.
PPIs can cause serious skin reactions, diarrhea, nausea, headaches and abdominal pain. Taking them accidentally could mask stomach issues, such as ulcers or cancer, or interact with other medications, with potentially dangerous side effects.
The UMARY tablets were sold as hyaluronic acid supplements. Hyaluronic acid is a slippery substance found throughout the body and often used in cosmetic and skincare products for its moisturizing and anti-aging properties.
When swallowed in tablets, hyaluronic acid may reduce arthritis pain, improve skin health, relieve joint stiffness and more.
MXBBB had not received any reports of adverse events related to this recall, as of Tuesday.
Consumers who are experiencing health problems that may be related to this product should contact their healthcare provider for help. Anyone with the recalled product should stop using it or return it to the place of purchase for a refund.
Consumers with questions about this recall can call MXBBB on (915)259-6936 or email joshua9808@outlook.com.
This recall affects 321 units of UMARY Hyaluronic Acid with the lot number 24183, the product code 7502265120323 and the expiration date 07/01/2024.
The supplements were sold in white, blue and black bottles containing 30 caplets of 850mg strength.
Newsweek has approached MXBBB for comment via email.
Other recalls include anxiety medication, clonazepam, which was mislabeled with incorrect dosage information and cinnamon rolls were recalled because they contain pieces of plastic.
Do you have a tip on a food story that Newsweek should be covering? Is there a nutrition concern that's worrying you? Let us know via science@newsweek.com. We can ask experts for advice, and your story could be featured in Newsweek.
English (US) ·